BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 34675611)

  • 1. Construction of a Ferroptosis-Related Gene Signature for Predicting Survival and Immune Microenvironment in Melanoma Patients.
    Zeng N; Ma L; Cheng Y; Xia Q; Li Y; Chen Y; Lu Z; Lu Q; Jiang F; Luo D
    Int J Gen Med; 2021; 14():6423-6438. PubMed ID: 34675611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy.
    Xu Z; Xie Y; Mao Y; Huang J; Mei X; Song J; Sun Y; Yao Z; Shi W
    Front Genet; 2021; 12():758981. PubMed ID: 34804126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
    Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
    Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
    Wu M; Wang Z; Zhang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma.
    Ping S; Wang S; Zhao Y; He J; Li G; Li D; Wei Z; Chen J
    Cancer Med; 2022 Sep; 11(18):3529-3541. PubMed ID: 35373463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
    Tian Q; Gao H; Zhao W; Zhou Y; Yang J
    Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new ferroptosis-related genetic mutation risk model predicts the prognosis of skin cutaneous melanoma.
    He J; Huang W; Li X; Wang J; Nie Y; Li G; Wang X; Cao H; Chen X; Wang X
    Front Genet; 2022; 13():988909. PubMed ID: 36685905
    [No Abstract]   [Full Text] [Related]  

  • 8. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma.
    Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y
    Front Surg; 2022; 9():860806. PubMed ID: 35937602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma Molecular Subtypes and Development of Prognostic and Immunotherapy-Related Genetic Characteristics by Ferroptosis Gene Analysis.
    Xu L; Zhang Y; Liu T; Wang L; Zhao Z; Zhang X; Li X; Wu W; Yu S
    Comput Math Methods Med; 2022; 2022():2992939. PubMed ID: 35516454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Ferroptosis-Related lncRNA Prognostic Model and Immune Infiltration Features in Skin Cutaneous Melanoma.
    Sun S; Zhang G; Zhang L
    Front Cell Dev Biol; 2021; 9():790047. PubMed ID: 35186949
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma.
    Guo S; Chen J; Yi X; Lu Z; Guo W
    Front Immunol; 2022; 13():985051. PubMed ID: 36248853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative lactylation and tumor microenvironment signature as prognostic and therapeutic biomarkers in skin cutaneous melanoma.
    Zhu Y; Song B; Yang Z; Peng Y; Cui Z; Chen L; Song B
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17897-17919. PubMed ID: 37955686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response.
    Liu J; Zhang Z; Liu X; Zhang W; Meng L; Wang J; Lv Z; Xia H; Zhang Y; Wang J
    World J Surg Oncol; 2022 Feb; 20(1):47. PubMed ID: 35209909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma.
    Hu B; Wei Q; Zhou C; Ju M; Wang L; Chen L; Li Z; Wei M; He M; Zhao L
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107162. PubMed ID: 33168410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and Identification of an NLR-Associated Prognostic Signature Revealing the Heterogeneous Immune Response in Skin Cutaneous Melanoma.
    Geng Y; Sun YJ; Song H; Miao QJ; Wang YF; Qi JL; Xu XL; Sun JF
    Clin Cosmet Investig Dermatol; 2023; 16():1623-1639. PubMed ID: 37396711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of coagulation-related gene signature to predict prognosis and tumor immune microenvironment in skin cutaneous melanoma.
    Song B; Chi H; Peng G; Song Y; Cui Z; Zhu Y; Chen G; Wu J; Liu W; Dong C; Wang Y; Xu K; Yu Z; Song B
    Front Oncol; 2022; 12():975255. PubMed ID: 36059641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel pyroptosis-related LncRNA signature predicts prognosis and indicates tumor immune microenvironment in skin cutaneous melanoma.
    Zhong J; Wang Z; Houssou Hounye A; Liu J; Zhang J; Qi M
    Life Sci; 2022 Oct; 307():120832. PubMed ID: 35940218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
    Liu X; Wang J
    Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.
    Xie Y; Xu Z; Mei X; Shi W
    Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of ferroptosis-related genes and prognosis of cutaneous melanoma.
    Liu C; Liu Y; Yu Y; Zhao Y; Yu A
    BMC Med Genomics; 2022 Mar; 15(1):39. PubMed ID: 35232428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.